Re: RVX Announces 2nd Positive Recommendation From DSMB

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: RVX Announces 2nd Positive Recommendation From DSMB

in response to

Re: RVX Announces 2nd Positive Recommendation From DSMB

SanFrancisco99

posted on Dec 05, 2016 01:18PM

SanFran,

I think you are reading too much into the efficacy comment. In my opinion (of course I can't speak for the DSMB), as long as apabetalone is not INCREASING the incidence of 3-point MACE events or all-cause mortality, then there should be no efficacy concerns. I don't think the statement in today's news release can be interpreted as indicating that apabetalone is decreasing 3-point MACE events. The futility analysis around mid 2017 will be the first true assessment of whether apabetalone is trending towards decreaseing 3-point MACE events.